Retatrutide 40 mg

Control. Discipline. Progress.

Investigational triple-receptor peptide agonist supplied as lyophilised powder for laboratory research only. Not approved for any human use.

Presentation: 40 mg lyophilised powder, sealed glass vial
Form: Lyophilised powder
Contents: 1 vial per unit
Analytical method: HPLC (reported on the batch certificate of analysis)
Reported result: See batch COA — no purity figure is published without a matching lab report
Batch / lot: AP-2406-F6

Verify this batch

Checkout and payment are not connected in this preview build

Storage information

· Store sealed vials at 2–8 °C, protected from light.
· Keep away from moisture and direct heat.
· Handling, reconstitution and disposal remain the responsibility of the receiving laboratory.

COA / test report

A laboratory report is recorded against batch AP-2406-F6. Open the verification page for the report details.

COA library

Research information

· Laboratory research material. Not for human or veterinary use.
· Educational and research information only — no therapeutic, diagnostic or treatment claim is made.
· This compound is investigational and is not authorised as a medicine in any jurisdiction.

Citations

Peer-reviewed reference to be added — Reference pending

Research and educational information only. No dosing guidance, treatment claim, disease claim or medical efficacy claim is made or implied. This material is not a medicine and is not for human or veterinary use.